Results 1 to 10 of about 53,297 (154)
α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.
α-Synuclein misfolding and aggregation is often accompanied by β-amyloid deposition in some neurodegenerative diseases. We hypothesised that α-synuclein promotes β-amyloid production from APP.
Hazel L Roberts +2 more
doaj +1 more source
Several lines of evidence suggest that accumulation of aggregated alpha-synuclein (α-synuclein) in the central nervous system (CNS) is an early pathogenic event in Parkinson's disease and other Lewy body disorders.
Veronica Lindström +14 more
doaj +1 more source
Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production
Variations in the α-synuclein-encoding SNCA gene represent the greatest genetic risk factor for Parkinson's disease (PD), and duplications/triplications of SNCA cause autosomal dominant familial PD.
Rikke H. Kofoed +9 more
doaj +1 more source
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
In Parkinson’s disease (PD) there is widespread accumulation in the brain of abnormal α-synuclein aggregates forming intraneuronal Lewy bodies (LB). It is now well established that LB-type α-synuclein aggregates also occur in the peripheral autonomic ...
Ariadna Recasens +6 more
doaj +1 more source
Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated α-synuclein are the signature neuropathological hallmark of multiple system atrophy (MSA).
Zuzana Krejciova +3 more
doaj +1 more source
Elevated plasma levels of alpha-synuclein are dispensable for Parkinson’s disease pathology
Although α-synuclein levels are elevated in the blood plasma of Parkinson’s disease (PD) patients, it remains unclear whether blood-derived α-synuclein directly contributes to PD.
Jin-Young Jeong +5 more
doaj +1 more source
Introduction: Cell therapeutic clinical trials using fetal mesencephalic tissue provided a proof-of-concept for regenerative therapy in patients with Parkinson's disease.
Serina Gima +7 more
doaj +1 more source
Elevated α-synuclein levels inhibit mitophagic flux
The pathogenic effect of SNCA gene multiplications indicates that elevation of wild-type α-synuclein levels is sufficient to cause Parkinson’s disease (PD). Mitochondria have been proposed to be a major target of α-synuclein-induced damage.
Inge Kinnart +8 more
doaj +1 more source
Intracellular Catalytic Photooxygenation of α‐Synuclein Amyloid
The amyloid aggregation of α‐synuclein is a central pathological hallmark of various synucleinopathies, including Parkinson disease. Consequently, developing strategies to eliminate α‐synuclein amyloids represents a promising therapeutic approach.
Atsushi Iwai +11 more
doaj +1 more source

